company background image
CFMS logo

Conformis NasdaqCM:CFMS Stock Report

Last Price

US$2.26

Market Cap

US$17.8m

7D

0%

1Y

-65.2%

Updated

06 Sep, 2023

Data

Company Financials +

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Conformis, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Conformis
Historical stock prices
Current Share PriceUS$2.26
52 Week HighUS$7.25
52 Week LowUS$1.05
Beta1.39
1 Month Change0.44%
3 Month Change96.52%
1 Year Change-65.23%
3 Year Change-87.44%
5 Year Change-91.93%
Change since IPO-99.53%

Recent News & Updates

Recent updates

Conformis stock jumps 17% aftermarket on FDA 510(k) clearance for Actera hip system

Sep 13

Conformis signs agreement with Vizient for personalized orthopedic implants

Aug 01

Investors Will Want Conformis' (NASDAQ:CFMS) Growth In ROCE To Persist

Jan 11
Investors Will Want Conformis' (NASDAQ:CFMS) Growth In ROCE To Persist

We Think Conformis (NASDAQ:CFMS) Can Stay On Top Of Its Debt

Dec 21
We Think Conformis (NASDAQ:CFMS) Can Stay On Top Of Its Debt

What Does Conformis, Inc.'s (NASDAQ:CFMS) Share Price Indicate?

Nov 11
What Does Conformis, Inc.'s (NASDAQ:CFMS) Share Price Indicate?

Is Conformis (NASDAQ:CFMS) A Risky Investment?

Sep 16
Is Conformis (NASDAQ:CFMS) A Risky Investment?

Conformis: Emerging Surgical Implant Developer

Sep 04

Shareholders Shouldn’t Be Too Comfortable With Conformis' (NASDAQ:CFMS) Strong Earnings

Aug 11
Shareholders Shouldn’t Be Too Comfortable With Conformis' (NASDAQ:CFMS) Strong Earnings

Party Time: Brokers Just Made Major Increases To Their Conformis, Inc. (NASDAQ:CFMS) Earnings Forecasts

Aug 10
Party Time: Brokers Just Made Major Increases To Their Conformis, Inc. (NASDAQ:CFMS) Earnings Forecasts

Increases to Conformis, Inc.'s (NASDAQ:CFMS) CEO Compensation Might Cool off for now

May 18
Increases to Conformis, Inc.'s (NASDAQ:CFMS) CEO Compensation Might Cool off for now

Analysts Just Shipped An Incredible Upgrade To Their Conformis, Inc. (NASDAQ:CFMS) Estimates

May 11
Analysts Just Shipped An Incredible Upgrade To Their Conformis, Inc. (NASDAQ:CFMS) Estimates

Conformis wins FDA clearance for Identity Imprint Knee Replacement System

May 10

Is Conformis (NASDAQ:CFMS) Using Debt Sensibly?

May 08
Is Conformis (NASDAQ:CFMS) Using Debt Sensibly?

ConforMIS EPS misses by $0.02, beats on revenue

May 05

Is Conformis (NASDAQ:CFMS) Using Too Much Debt?

Jan 16
Is Conformis (NASDAQ:CFMS) Using Too Much Debt?

Shareholder Returns

CFMSUS Medical EquipmentUS Market
7D0%2.2%0.4%
1Y-65.2%13.3%28.8%

Return vs Industry: CFMS underperformed the US Medical Equipment industry which returned 3.9% over the past year.

Return vs Market: CFMS underperformed the US Market which returned 11.1% over the past year.

Price Volatility

Is CFMS's price volatile compared to industry and market?
CFMS volatility
CFMS Average Weekly Movement25.0%
Medical Equipment Industry Average Movement7.7%
Market Average Movement6.0%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market3.0%

Stable Share Price: CFMS's share price has been volatile over the past 3 months.

Volatility Over Time: CFMS's weekly volatility has increased from 20% to 25% over the past year.

About the Company

FoundedEmployeesCEOWebsite
2004295Mark Augustihttps://www.conformis.com

Conformis, Inc., a medical technology company, develops, manufactures, and sells patient-specific products and instrumentation. The company offers personalized knee replacement products, including iUni, iDuo, iTotal CR, and iTotal PS, as well as provides iTotal Identity and Identity Imprint knee replacement products. It also offers Conformis Hip System and Cordera hip replacement, which are hip replacement products; and iJigs, a personalized single-use patient-specific instrumentation.

Conformis, Inc. Fundamentals Summary

How do Conformis's earnings and revenue compare to its market cap?
CFMS fundamental statistics
Market capUS$17.80m
Earnings (TTM)-US$41.50m
Revenue (TTM)US$57.06m

0.3x

P/S Ratio

-0.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CFMS income statement (TTM)
RevenueUS$57.06m
Cost of RevenueUS$38.12m
Gross ProfitUS$18.95m
Other ExpensesUS$60.45m
Earnings-US$41.50m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-5.27
Gross Margin33.21%
Net Profit Margin-72.73%
Debt/Equity Ratio64.4%

How did CFMS perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.